$3.75
0.030.81%
At close: -
$3.78
0.030.82%
After Hours: May 1, 8:00 AM EDT
Comments
Loading...
Kala Bio Insider Trading Activity | NASDAQ:KALA | Benzinga
Track the latest Kala Bio insider trading activity. Stay informed on recent buys, sells, and market impact for Kala Bio stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Kala Bio Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Kala Bio Inc
Shares Outstanding
6.091M
Insider Shares Owned
1.275M
Insider Percentage Owned
19.8%
Institutional Shares Held
214.818K
Institutional Percentage Held
3.33%
| Jan 07, 2025 | Darius Kharabi | CHIEF BUSINESS OFFICER | 8.08K | $7.63 | -$15.42K | GRANT | 13.53% | 67.81K | Jan 06 | View |
| Jan 07, 2025 | Todd Bazemore | SEE REMARKS | 8.11K | $7.63 | -$15.21K | GRANT | ∞ | 1.00 | Jan 06 | View |
| Jan 07, 2025 | Romulus Brazzell | SEE REMARKS | 7.65K | $7.63 | -$18.66K | GRANT | 9.03% | 92.42K | Jan 06 | View |
| Jan 07, 2025 | Mark Iwicki | CHIEF EXECUTIVE OFFICER | 16.32K | $7.63 | -$44.09K | GRANT | 6.19% | 280.08K | Jan 06 | View |
| Jan 07, 2025 | Mary Reumuth | CHIEF FINANCIAL OFFICER | 8.39K | $7.63 | -$13.02K | GRANT | 13.95% | 68.58K | Jan 06 | View |
| Dec 31, 2024 | BAKER BROS ADVISORS LPBaker Bros Advisors GP LLCFELIX BAKERJULIAN BAKER | — | 310.56K | $6.44 | $2.00M | BUY | 40.18% | 1.08M | Dec 30 | View |
| Jun 27, 2024 | Todd Bazemore | SEE REMARKS | -4.65K | $4.75 | -$22.10K | SELL | -5.31% | 83.04K | Jun 26 | View |
| Jun 27, 2024 | Darius Kharabi | CHIEF BUSINESS OFFICER | -5.16K | $4.75 | -$24.50K | SELL | -7.95% | 59.73K | Jun 26 | View |
| Jun 27, 2024 | Mary Reumuth | CHIEF FINANCIAL OFFICER | -4.16K | $4.75 | -$19.77K | SELL | -6.47% | 60.19K | Jun 26 | View |
| Jun 27, 2024 | Mark Iwicki | CHIEF EXECUTIVE OFFICER | -15.17K | $4.75 | -$72.05K | SELL | -5.44% | 263.75K | Jun 26 | View |
| Jun 27, 2024 | Romulus Brazzell | SEE REMARKS | -5.49K | $4.75 | -$26.07K | SELL | -6.13% | 83.98K | Jun 26 | View |
| Jun 03, 2024 | Todd Bazemore | SEE REMARKS | -2.09K | $6.09 | -$12.75K | SELL | -2.33% | 87.69K | May 31 | View |
| Jun 03, 2024 | Darius Kharabi | CHIEF BUSINESS OFFICER | -231.00 | $6.09 | -$1.41K | SELL | -0.35% | 64.89K | May 31 | View |
| Jun 03, 2024 | Mary Reumuth | CHIEF FINANCIAL OFFICER | -1.79K | $6.09 | -$10.88K | SELL | -2.70% | 64.35K | May 31 | View |
| Jun 03, 2024 | Romulus Brazzell | SEE REMARKS | -2.00K | $6.09 | -$12.19K | SELL | -2.19% | 89.47K | May 31 | View |
| Jun 03, 2024 | Mark Iwicki | CHIEF EXECUTIVE OFFICER | -7.39K | $6.09 | -$45.02K | SELL | -2.58% | 278.92K | May 31 | View |
| Jan 05, 2024 | Eric Trachtenberg | SEE REMARKS | 3.37K | $6.74 | -$8.27K | GRANT | 5.21% | 68.07K | Jan 04 | View |
| Jan 05, 2024 | Darius Kharabi | CHIEF BUSINESS OFFICER | 3.21K | $6.73 | -$9.32K | GRANT | 5.19% | 65.12K | Jan 04 | View |
| Jan 05, 2024 | Romulus Brazzell | SEE REMARKS | 4.88K | $6.74 | -$10.90K | GRANT | 5.64% | 91.47K | Jan 04 | View |
| Jan 05, 2024 | Mark Iwicki | CHIEF EXECUTIVE OFFICER | 9.76K | $6.73 | -$30.55K | GRANT | 3.53% | 286.31K | Jan 04 | View |
| Jan 05, 2024 | Mary Reumuth | CHIEF FINANCIAL OFFICER | 3.37K | $6.74 | -$8.27K | GRANT | 5.37% | 66.14K | Jan 04 | View |
| Jan 05, 2024 | Todd Bazemore | SEE REMARKS | 5.09K | $6.74 | -$9.47K | GRANT | ∞ | 1.00 | Jan 04 | View |
| Jan 06, 2023 | Eric Trachtenberg | SEE REMARKS | 9.46K | $28.55 | -$1.71K | GRANT | 466.26% | 11.49K | Jan 04 | View |
| Jan 06, 2023 | Mary Reumuth | CHIEF FINANCIAL OFFICER | 9.46K | $28.54 | -$1.71K | GRANT | 391.44% | 11.88K | Jan 04 | View |
| Jan 06, 2023 | Romulus Brazzell | SEE REMARKS | 12.73K | $28.53 | -$2.08K | GRANT | 219.09% | 18.54K | Jan 04 | View |
| Jan 06, 2023 | Todd Bazemore | SEE REMARKS | 12.74K | $28.54 | -$1.77K | GRANT | 607.15% | 14.84K | Jan 04 | View |
| Jan 06, 2023 | Mark Iwicki | CHIEF EXECUTIVE OFFICER | 41.50K | $28.54 | -$5.65K | GRANT | 929.70% | 45.97K | Jan 04 | View |
| Oct 28, 2022 | Eric Trachtenberg | SEE REMARKS | -194.00 | $6.52 | -$1.26K | SELL | -8.72% | 2.03K | Oct 26 | View |
| Oct 28, 2022 | Todd Bazemore | SEE REMARKS | -214.00 | $6.51 | -$1.39K | SELL | -9.26% | 2.10K | Oct 26 | View |
| Oct 28, 2022 | Mary Reumuth | CHIEF FINANCIAL OFFICER | -194.00 | $6.51 | -$1.26K | SELL | -7.43% | 2.42K | Oct 26 | View |
| Oct 28, 2022 | Romulus Brazzell | SEE REMARKS | -261.00 | $6.51 | -$1.70K | SELL | -4.30% | 5.81K | Oct 26 | View |
| Oct 28, 2022 | Mark Iwicki | CHIEF EXECUTIVE OFFICER | -561.00 | $6.52 | -$3.66K | SELL | -11.16% | 4.46K | Oct 26 | View |
| Jun 29, 2022 | Eric Trachtenberg | SEE REMARKS | -2.61K | $0.37 | -$966.81 | SELL | -2.30% | 111.20K | Jun 27 | View |
| Jun 29, 2022 | Mary Reumuth | CHIEF FINANCIAL OFFICER | -2.61K | $0.37 | -$966.81 | SELL | -1.96% | 130.59K | Jun 27 | View |
| Jun 29, 2022 | Romulus Brazzell | SEE REMARKS | -3.14K | $0.37 | -$1.16K | SELL | -1.09% | 285.20K | Jun 27 | View |
| Jun 29, 2022 | Todd Bazemore | SEE REMARKS | -3.09K | $0.37 | -$1.14K | SELL | -2.61% | 115.54K | Jun 27 | View |
| Jun 29, 2022 | Mark Iwicki | CHIEF EXECUTIVE OFFICER | -7.97K | $0.37 | -$2.95K | SELL | -3.08% | 251.18K | Jun 27 | View |
| May 26, 2022 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPPeter KolchinskyRajeev Shah | 10% OWNER | -1.01M | $0.36 | -$365.67K | SELL | -12.50% | 7.04M | May 26 | View |
| May 25, 2022 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPPeter KolchinskyRajeev Shah | 10% OWNER | -2.83M | $0.53 | -$1.49M | SELL | -26.02% | 8.05M | May 23 - May 25 | View |
| Jan 05, 2022 | Mary Reumuth | CHIEF FINANCIAL OFFICER | -2.85K | $1.30 | -$3.71K | SELL | -2.09% | 133.21K | Jan 04 | View |
| Jan 05, 2022 | Romulus Brazzell | SEE REMARKS | -3.50K | $1.30 | -$4.56K | SELL | -1.20% | 288.35K | Jan 04 | View |
| Jan 05, 2022 | Todd Bazemore | SEE REMARKS | -3.45K | $1.30 | -$4.49K | SELL | -2.83% | 118.63K | Jan 04 | View |
| Jan 05, 2022 | Mark Iwicki | CHIEF EXECUTIVE OFFICER | -9.52K | $1.30 | -$12.37K | SELL | -3.54% | 259.16K | Jan 04 | View |
| Jan 05, 2022 | Eric Trachtenberg | SEE REMARKS | -2.85K | $1.30 | -$3.71K | SELL | -2.44% | 113.82K | Jan 04 | View |
| Oct 28, 2021 | Hongming Chen | CHIEF SCIENTIFIC OFFICER | -30.50K | $1.81 | -$55.32K | SELL | -12.98% | 204.51K | Oct 26 - Oct 27 | View |
| Oct 28, 2021 | Eric Trachtenberg | SEE REMARKS | -9.45K | $1.80 | -$17.01K | SELL | -7.49% | 116.67K | Oct 26 | View |
| Oct 28, 2021 | Mary Reumuth | CHIEF FINANCIAL OFFICER | -9.45K | $1.80 | -$17.01K | SELL | -6.49% | 136.06K | Oct 26 | View |
| Oct 28, 2021 | Todd Bazemore | CHIEF OPERATING OFFICER | -12.54K | $1.80 | -$22.58K | SELL | -9.32% | 122.09K | Oct 26 | View |
| Oct 28, 2021 | Romulus Brazzell | CHIEF MEDICAL OFFICER | -12.76K | $1.80 | -$22.96K | SELL | -4.19% | 291.85K | Oct 26 | View |
| Oct 28, 2021 | Mark Iwicki | CHIEF EXECUTIVE OFFICER | -27.60K | $1.80 | -$49.68K | SELL | -9.32% | 268.68K | Oct 26 | View |
| Jun 30, 2021 | Hongming Chen | CHIEF SCIENTIFIC OFFICER | -5.55K | $5.56 | -$30.85K | SELL | -2.31% | 235.01K | Jun 29 | View |
| Jun 29, 2021 | Hongming Chen | CHIEF SCIENTIFIC OFFICER | -2.45K | $5.77 | -$14.15K | SELL | -1.01% | 240.56K | Jun 28 | View |
| Jun 29, 2021 | Romulus Brazzell | CHIEF MEDICAL OFFICER | -3.03K | $5.77 | -$17.51K | SELL | -1.00% | 300.96K | Jun 28 | View |
| Jun 29, 2021 | Eric Trachtenberg | SEE REMARKS | -2.45K | $5.77 | -$14.15K | SELL | -1.91% | 126.11K | Jun 28 | View |
| Jun 29, 2021 | Mary Reumuth | CHIEF FINANCIAL OFFICER | -2.45K | $5.77 | -$14.15K | SELL | -1.66% | 145.51K | Jun 28 | View |
| Jun 29, 2021 | Todd Bazemore | CHIEF OPERATING OFFICER | -2.91K | $5.77 | -$16.80K | SELL | -98.58% | 42.00 | Jun 28 | View |
| Jun 29, 2021 | Mark Iwicki | CHIEF EXECUTIVE OFFICER | -7.59K | $5.77 | -$43.77K | SELL | -2.50% | 296.27K | Jun 28 | View |
| Oct 28, 2020 | Todd Bazemore | — | 81.04K | $7.88 | $330.78 | GRANT OR AWARD | ∞ | 42.00 | Jun 05 - Oct 26 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
